HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Interpretive Summary Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fan, W. Articles by Kerr, D. E. Search for Related Content PubMed PubMed Citation Articles by Fan, W. Articles by Kerr, D. E.

Persistency of Adenoviral-Mediated Lysostaphin Expression in Goat Mammary Glands

Department of Animal Science, College of Agriculture & Life Sciences, University of Vermont, Burlington 05405

Corresponding author: D. E. Kerr; e-mail: dkerr{at}zoo.uvm.edu.

Gene therapy has great potential to enable synthesis of protein molecules in targeted cells of an animal. One application may be the production of antibacterial enzymes by the mammary gland as a means of preventing or treating mastitis. We have previously demonstrated that goat mammary cells are capable of producing lysostaphin, an antistaphylococcal enzyme, after being transduced in vivo with a recombinant adenoviral vector containing a modified lysostaphin gene (Ad-lys). The current study examined duration of expression, and antibody response to lysostaphin and the adenoviral vector. Following intramammary infusion into nonlactating goats (n = 4), recovery of transducible adenoviral vector in mammary secretions persisted for 11 d. Transducible vector was not detected in serum, saliva, urine, or feces. Peak lysostaphin concentrations (< 20 µg/mL) in mammary secretions of infused udders were detected approximately 1 wk postinfusion, and generally returned to undetectable levels after an additional 1 to 2 wk. The poor persistency of expression was likely due to the very potent immune response to both the adenovirus and the expressed lysostaphin. Serum IgG antibodies recognizing the adenoviral vector developed within 7 d of the infusion, and titers rose dramatically to greater than 1:1 x 10⁵. Similar titers of serum IgG antibodies to lysostaphin developed in 3 goats, with more moderate titers in the fourth goat. The antibody response to lysostaphin was delayed by approximately 4 d in comparison to the response to the adenovirus. Serum IgG antibody profiles were reflected in mammary secretions. No IgA antibodies to adenovirus or lysostaphin were detected in sera or mammary secretion. We demonstrate that while the lysostaphin gene can be introduced to the mammary gland using an adenoviral-mediated gene transfer technique, the strong immune response that it provokes makes the approach unsuitable for combating mastitis.

Key Words: adenovirus • lysostaphin • mastitis • antibody

Abbreviation key: Ad-lacZ = adenoviral vector containing the E.coli lacZ gene, Ad-lys = adenoviral vector containing a modified lysostaphin gene, BAV-3 = bovine adenovirus type 3, BHV-1 = bovine herpesvirus type 1, HD-Ad = helper-dependent adenoviral vector, FIX = factor IX, gD = glycoprotein D, PBS-T = PBS-0.1% Tween 20, PBS-T-G = PBS-0.1% Tween 20-0.1% gelatin

This article has been cited by other articles:

				J. X. Zhang, S. F. Zhang, T. D. Wang, X. J. Guo, and R. L. Hu Mammary Gland Expression of Antibacterial Peptide Genes to Inhibit Bacterial Pathogens Causing Mastitis J Dairy Sci, November 1, 2007; 90(11): 5218 - 5225. [Abstract] [Full Text] [PDF]